Aug. 12 at 7:41 PM
$SLS
SLS009 / Tambiciclib Published Phase 2 data at ASH for AML-MR Patients - AML-MR patients have the worse Prognosis - that was Better than P1B AML-MR Data published
$FTSV that
$GILD Bought for
$5B
- the Market Has yet to appreciate SLS009 value.
Some Well Known BLOCKBUSTER KINASE INHIBITORS
Gleevic - Imatinib
Imbrutinib - Imbruvica
Upadactinib - Rinvoq
$PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor
Novartis' Kisqali -Ribociclib CDKinase Inhibitor
$LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor
SLS009 Tambiciclib CDKInase Inhibitor.